All these data highlight the importance of PI3K/AKT, Sirt1/AMPK/ACC, and apoptosis in T2DM and the possible beneficial role of GLP-1 analogs in modulating these cellular response pathways to lower blood glucose and attenuate diabetes-related liver injury. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.